Senior Medical Director in Weybridge

Come and Save Lives with Us! SERB is a fast-growing specialty pharmaceutical company that equips healthcare providers worldwide with life-saving medicines for patients facing rare conditions and emergencies. For over 30 years we have consistently provided emergency medicines, medical countermeasures, and the world’s leading portfolio of antidotes. Today SERB has over 600 employees in 18 countries and group revenue in excess of €500m. With a strong presence in the US, UK, Europe, and the Middle East, along with a global network of trusted distribution partners, we make a broad range of essential medicines available in over 100 countries.

Having the right culture is as important to us as having the right portfolio. We are guided by our four values:

• We make patients our priority
• We act with accountability and integrity
• We work together as one team
• We look for better ways forward

By expanding our reach through selective acquisitions and entering new markets, we’re not just supplying medicine, we’re improving the standard of care for more patients around the world.

Broad Overview

The Senior Director, Medical Oncology provides strategic scientific and clinical leadership for oncology assets across their lifecycle. This role ensures the integration of medical expertise into clinical development plans, medical communications, launch strategies, evidence generation, and external stakeholder engagement. The Senior Director serves as a key bridge between clinical R&D, commercial partners, regulatory affairs, and the external oncology community to support successful development and commercialization of oncology products.

Your responsibilities include:

• Scientific & Medical Strategy: Develop and shape medical/scientific strategy for SERB’s oncology portfolio for the International markets. Integrate competitive intelligence, scientific trends, and regional clinical practice insights into development plans. Contribute to long‑term portfolio strategy and monitor evolving oncology science, standards of care, and competitive landscapes to inform strategic decisions.
• Cross‑Functional & Cross‑Regional Leadership: Collaborate with all functions, providing medical input, guidance and training. Lead International cross‑functional project teams, providing medical direction to Clinical Operations, Regulatory, Safety, Biometrics, and Commercial colleagues. Partner with US and EU Medical Affairs teams to support global scientific engagement, publication strategy, and launch readiness. Mentor and develop local Medical leads, Clinical Scientists, and regional medical leaders.
• External Engagement & Scientific Leadership/ Medical Affairs / Launch Readiness: Actively network with international external experts and clinical investigators, gaining insights to inform strategies, developing advocacy through credible scientific exchange, and facilitating collaboration with SERB projects. Execute medical affairs strategies, including KOL engagement, medical education, advisory boards, and congress plans, oncology networks. Engage in scientific discussions with other external stakeholders such as regulatory authorities, patient advocacy groups and alliance partners globally. Support launch readiness activities (indications, label expansions, real-world evidence plans, health economics). Lead global advisory boards, investigator meetings, and scientific engagement activities. Represent the company at major international congresses (ASCO, ESMO, AACR, ASH).
• Evidence Generation & Research: Oversee the direction, strategy and planning of oncology clinical development in International region. In collaboration with Clinical Development team, contribute to the development of protocols (e.g line extensions), ensuring quality of relevant clinical documents (e.g. Investigators’ Brochure, study reports, clinical components of regulatory submissions and safety related documents). Analyse and interpret clinical data, oversee safety in collaboration with relevant colleagues and participate in data monitoring committee meetings, as required. Oversee investigator-initiated studies (IISs), post-marketing studies, real-world evidence initiatives, and data dissemination plans. You will participate in cross-functional teams to generate, deliver, and interpret high-quality clinical data supporting overall product strategy. Contribute to publication strategies, abstracts, manuscripts, and conference presentations. Ensure all scientific communications are medically accurate, balanced, and compliant.
• Other: Ensuring that all interactions and engagements are carried out with the highest ethical and professional standards and that all work is accomplished with quality and in accordance with SERB values. Carry out other reasonable tasks as required by the Line Manager. The above duties and responsibilities are not an exhaustive list, and you may be required to undertake any other reasonable duties compatible with your experience and competencies. This description may be varied from time to time to reflect changing business requirements.

To be successful in this role, you should demonstrate:

• Medical degree (MD or equivalent).
• Experience in oncology clinical development Phase II-IV (minimum 5 years).
• Experience in Medical Affairs leadership roles (minimum 5 years).
• Strategic thinking and expertise in developing strong medical and clinical strategies.
• Strong understanding of global regulatory pathways (FDA, EMA, MHRA).
• Demonstrated success in cross‑regional collaboration, teamwork and matrix leadership.
• Deep scientific and clinical expertise in oncology development.
• Strong communication and collaboration skills, both internally and with external parties.
• Strong judgement and decision‑making.
• Self-driven, ability to work independently, taking ownership and leadership for area of responsibility.
• Result-oriented and committed to contributing to the overall success.
• A can-do, proactive and positive mindset.

Company Benefits:

• 25 annual leave days plus bank holidays and 3 annual company closure days (to be taken between Christmas and New year).
• Competitive Pension Scheme.
• Private Medical Insurance.
• Discretionary Bonus Plan.
• Paid Maternity and Paternity Leave.
• Academic Study Assistance.
• Eyecare vouchers.
• Employee Assistance Programme.